Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
US7452907B2 · kind B2 · utility
19Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2006 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Oct 14, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided which have the structurewherein Q is C or N, X1 is C or N, and R1, R2, R2a, R2b, R2c, R3, Y, A, m, n, X2, X3 and X4 are as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.